Anthony Lakavage is Senior Vice President, Global External Affairs and Secretary of the USP Convention and Board of Trustees. He oversees global communications, public policy, stakeholder engagement, and the USP Quality Institute. As the architect of USP’s external engagement strategy, he represents USP before the FDA, Congress, international regulators, and global health organizations. He works closely with USP’s 450 Convention member organizations and supports the Board on strategy and risk management. A veteran of GlaxoSmithKline, Gilead, and BD, he brings over 20 years of experience across pharma, vaccines, and medtech. He holds a B.A. in International Politics from Saint Joseph’s University and a J.D. from Temple University, and is admitted to the bar in Pennsylvania and New Jersey.